Welcome!

News Feed Item

Before the Bell Scans of MannKind, Ariad Pharma, ZIOPHARM Oncology, NPS Pharma, and Santarus

LONDON, March 22, 2013 /PRNewswire/ --

Biotechnology companies are expected to face significant challenges in the near future due to rising costs related to the Affordable Care Act (ACA). Increasing generic competition is also putting pressure on companies' top-line growth. Going forward, the key for companies such as MannKind Corporation (NASDAQ: MNKD), Ariad Pharmaceuticals Inc. (NASDAQ: ARIA), ZIOPHARM Oncology Inc. (NASDAQ: ZIOP), NPS Pharmaceuticals Inc. (NASDAQ: NPSP), and Santarus Inc. (NASDAQ: SNTS) will be to bring new and potential blockbuster drugs to the market. Biotechnology companies will be looking to form collaboration with major pharmaceutical companies as well as academic institutions to develop potential blockbuster drugs. On Thursday, biotechnology stocks ended on a mixed note as the broad market tumbled on concerns over Cyprus's bailout. StockCall has taken an interest in these companies and you can now sign up to download the free technical research on MNKD, ARIA, ZIOP, NPSP, and SNTS at

http://www.stockcall.com/registration  

MannKind Corporation shares posted modest gains in trading on Thursday even as the broad market struggled. The stock closed 0.60% higher at $3.37 on volume of 3.40 million. The stock hit an intra-day high of $3.42. MannKind's shares are currently trading close to their 52-week high of $3.67. The stock has had an excellent run so far in 2013, gaining nearly 46%. The stock's MACD chart is indicating that market sentiment has turned bearish on the stock. Sign up today to read the free research report on MNKD at

http://www.StockCall.com/MNKD032213.pdf

Shares of Ariad Pharmaceuticals Inc. fell sharply in yesterday's trading session, extending their losses from previous trading sessions. On Thursday, the stock ended the day 3.62% lower at $19.71 on above average volume of 3.18 million, taking its losses in the last three sessions to over 7.50%. The biotech company's shares have pared most of their gains for the year as a result of the recent sell-off. Year-to-date, the stock is now up just 2.76%. The stock has also slipped below its 50-day and 200-day moving averages, which is a bearish signal. The downbeat trend is further confirmed by the stock's MACD chart. Register to download the free technical analysis on ARIA at

http://www.StockCall.com/ARIA032213.pdf

ZIOPHARM Oncology Inc.'s shares tumbled in trading yesterday, continuing its downward slide. The stock finished 3.56% lower at $5.14 on above average volume of 1.79 million. In the last three sessions, the stock has now fallen nearly 10%. ZIOPHARM's shares have fallen after failing to break through $5.80 resistance level. The stock's MACD has just crossed below the signal line, which is a bearish signal. Free report on ZIOP can be accessed by registering at

http://www.StockCall.com/ZIOP032213.pdf

NPS Pharmaceuticals Inc.'s shares rose sharply even as the broad market slipped on Thursday. The stock continued its excellent run from the previous two trading sessions. The company's shares ended 1.65% higher at $9.84 on volume of 1.66 million, taking their gains in the last three sessions to nearly 9%. Year-to-date, the stock has gained more than 8%. Register with StockCall and download the research on NPSP for free at

http://www.StockCall.com/NPSP032213.pdf

Santarus Inc.'s shares edged higher on Thursday; however, the gains were limited. The stock closed 0.64% higher at $17.27 on volume of 938,032. The stock has gained nearly 4% in the last three trading sessions. The company's shares are currently trading close to their 52-week high of $17.74. The stock has had an excellent run so far in 2013, gaining more than 57%. Santarus' shares have seen a series of highs, which is a bullish signal. Read the full free research on SNTS by signing up to StockCall at

http://www.StockCall.com/SNTS032213.pdf  

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
For financial firms, the cloud is going to increasingly become a crucial part of dealing with customers over the next five years and beyond, particularly with the growing use and acceptance of virtual currencies. There are new data storage paradigms on the horizon that will deliver secure solutions for storing and moving sensitive financial data around the world without touching terrestrial networks. In his session at 20th Cloud Expo, Cliff Beek, President of Cloud Constellation Corporation, d...
Deep learning has been very successful in social sciences and specially areas where there is a lot of data. Trading is another field that can be viewed as social science with a lot of data. With the advent of Deep Learning and Big Data technologies for efficient computation, we are finally able to use the same methods in investment management as we would in face recognition or in making chat-bots. In his session at 20th Cloud Expo, Gaurav Chakravorty, co-founder and Head of Strategy Development ...
DevOps at Cloud Expo, taking place October 31 - November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 21st Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to w...
Vulnerability management is vital for large companies that need to secure containers across thousands of hosts, but many struggle to understand how exposed they are when they discover a new high security vulnerability. In his session at 21st Cloud Expo, John Morello, CTO of Twistlock, will address this pressing concern by introducing the concept of the “Vulnerability Risk Tree API,” which brings all the data together in a simple REST endpoint, allowing companies to easily grasp the severity of t...
The goal of Continuous Testing is to shift testing left to find defects earlier and release software faster. This can be achieved by integrating a set of open source functional and performance testing tools in the early stages of your software delivery lifecycle. There is one process that binds all application delivery stages together into one well-orchestrated machine: Continuous Testing. Continuous Testing is the conveyer belt between the Software Factory and production stages. Artifacts are m...
Recently, WebRTC has a lot of eyes from market. The use cases of WebRTC are expanding - video chat, online education, online health care etc. Not only for human-to-human communication, but also IoT use cases such as machine to human use cases can be seen recently. One of the typical use-case is remote camera monitoring. With WebRTC, people can have interoperability and flexibility for deploying monitoring service. However, the benefit of WebRTC for IoT is not only its convenience and interopera...
There is only one world-class Cloud event on earth, and that is Cloud Expo – which returns to Silicon Valley for the 21st Cloud Expo at the Santa Clara Convention Center, October 31 - November 2, 2017. Every Global 2000 enterprise in the world is now integrating cloud computing in some form into its IT development and operations. Midsize and small businesses are also migrating to the cloud in increasing numbers. Companies are each developing their unique mix of cloud technologies and service...
Connecting to major cloud service providers is becoming central to doing business. But your cloud provider’s performance is only as good as your connectivity solution. Massive Networks will place you in the driver's seat by exposing how you can extend your LAN from any location to include any cloud platform through an advanced high-performance connection that is secure and dedicated to your business-critical data. In his session at 21st Cloud Expo, Paul Mako, CEO & CIO of Massive Networks, wil...
Cloud resources, although available in abundance, are inherently volatile. For transactional computing, like ERP and most enterprise software, this is a challenge as transactional integrity and data fidelity is paramount – making it a challenge to create cloud native applications while relying on RDBMS. In his session at 21st Cloud Expo, Claus Jepsen, Chief Architect and Head of Innovation Labs at Unit4, will explore that in order to create distributed and scalable solutions ensuring high availa...
When shopping for a new data processing platform for IoT solutions, many development teams want to be able to test-drive options before making a choice. Yet when evaluating an IoT solution, it’s simply not feasible to do so at scale with physical devices. Building a sensor simulator is the next best choice; however, generating a realistic simulation at very high TPS with ease of configurability is a formidable challenge. When dealing with multiple application or transport protocols, you would be...
As businesses adopt functionalities in cloud computing, it’s imperative that IT operations consistently ensure cloud systems work correctly – all of the time, and to their best capabilities. In his session at @BigDataExpo, Bernd Harzog, CEO and founder of OpsDataStore, presented an industry answer to the common question, “Are you running IT operations as efficiently and as cost effectively as you need to?” He then expounded on the industry issues he frequently came up against as an analyst, and ...
SYS-CON Events announced today that App2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct. 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. App2Cloud is an online Platform, specializing in migrating legacy applications to any Cloud Providers (AWS, Azure, Google Cloud).
In his session at @DevOpsSummit at 20th Cloud Expo, Kelly Looney, director of DevOps consulting for Skytap, showed how an incremental approach to introducing containers into complex, distributed applications results in modernization with less risk and more reward. He also shared the story of how Skytap used Docker to get out of the business of managing infrastructure, and into the business of delivering innovation and business value. Attendees learned how up-front planning allows for a clean sep...
IoT is at the core or many Digital Transformation initiatives with the goal of re-inventing a company's business model. We all agree that collecting relevant IoT data will result in massive amounts of data needing to be stored. However, with the rapid development of IoT devices and ongoing business model transformation, we are not able to predict the volume and growth of IoT data. And with the lack of IoT history, traditional methods of IT and infrastructure planning based on the past do not app...
Blockchain is a shared, secure record of exchange that establishes trust, accountability and transparency across supply chain networks. Supported by the Linux Foundation's open source, open-standards based Hyperledger Project, Blockchain has the potential to improve regulatory compliance, reduce cost and time for product recall as well as advance trade. Are you curious about Blockchain and how it can provide you with new opportunities for innovation and growth? In her session at 20th Cloud Exp...